PriceTracker GLP-1

GLP-1 TV · Patient story · views checked Oct 2026

Eli Lilly's New GLP-1 pill Orforglipron (Foundayo) Explained | Why it's NOT just oral Zepbound

Patient storyGLP-1 Hub14,228 views11:32Apr 2026

Our summary

A patient explains how Wegovy works and what the evidence says, mentioning 17.2 mg. Also covers injection technique and the trials.

One person's experience, in their words. Not medical advice.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 A new weight loss pill that could shake things up
  2. 0:32 Why this matters if you’re comparing GLP-1 options
  3. 0:53 What Orforglipron is
  4. 1:33 Why Orforglipron is different from peptide GLP-1 drugs
  5. 3:21 Why the pill format may be easier for many people
  6. 3:49 Oral semaglutide comparison and dosing convenience
  7. 5:06 Who Orforglipron may be for
  8. 6:36 Trial results and expected weight loss

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy, Zepbound, Mounjaro and Foundayo
Doses mentioned
17.2 mg
Who is speaking
Patient

Find more like it

Side effectsDose changeWeigh-in and resultsInjection techniqueHow it worksThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV